Scarica l'app Stockscreener
4.52
3.81%
0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.33
Aprire:
$4.39
Volume 24 ore:
264.90K
Relative Volume:
1.76
Capitalizzazione di mercato:
$149.11M
Reddito:
-
Utile/perdita netta:
$-12.48M
Rapporto P/E:
-11.59
EPS:
-0.39
Flusso di cassa netto:
$-7.93M
1 W Prestazione:
+38.31%
1M Prestazione:
+53.15%
6M Prestazione:
+74.22%
1 anno Prestazione:
+49.34%
Intervallo 1D:
$4.3866
$4.6962
Intervallo di 1 settimana:
$3.35
$4.98
Portata 52W:
$2.07
$4.98
Anixa Biosciences Inc Stock (ANIX) Company Profile
Nome
Anixa Biosciences Inc
Settore
Industria
Telefono
408-708-9808
Indirizzo
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
Confronta ANIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
4.53 | 142.53M | 0 | -12.48M | -7.93M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-21 | Iniziato | Maxim Group | Buy |
| 2022-12-23 | Iniziato | Chardan Capital Markets | Buy |
| 2021-04-12 | Iniziato | H.C. Wainwright | Buy |
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Analyzing drawdowns of Anixa Biosciences Inc. with statistical toolsJuly 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
Developing predictive dashboards with Anixa Biosciences Inc. data2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com
Will Anixa Biosciences Inc. stock benefit from AI adoptionJuly 2025 Rallies & Detailed Earnings Play Strategies - newser.com
Is Anixa Biosciences Inc. stock a buy for dividend growthMarket Trend Summary & Daily Stock Trend Reports - newser.com
Live market analysis of Anixa Biosciences Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com
Why global investors buy Anixa Biosciences Inc. (CY71) stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Pattern recognition hints at Anixa Biosciences Inc. upsideJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Is Anixa Biosciences Inc. (CY71) stock positioned for digital growth eraJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Candlestick signals on Anixa Biosciences Inc. stock todayQuarterly Growth Report & Daily Entry Point Alerts - newser.com
Is Anixa's First-In-Human Vaccine Poised For Regulatory Momentum? - RTTNews
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial - The Malaysian Reserve
D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq
D. Boral Capital Maintains 'Buy' Rating and $10 PT on ANIX | ANI - GuruFocus
D. Boral Capital Reaffirms "Buy" Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat
Anixa Biosciences (ANIX) Concludes Key Breast Cancer Vaccine Tri - GuruFocus
Anixa Biosciences announces completion of final patient visit in breast cancer vaccine clinical trial - MarketScreener
Is a relief rally coming for Anixa Biosciences Inc. holders2025 Volume Leaders & Safe Capital Growth Trade Ideas - newser.com
When is the best time to exit Anixa Biosciences Inc.Market Sentiment Review & Community Trade Idea Sharing - newser.com
Anixa Biosciences Inc. stock trendline breakdownBuy Signal & Verified Short-Term Plans - newser.com
Can Anixa Biosciences Inc. (CY71) stock beat analyst consensusMarket Rally & High Yield Equity Trading Tips - newser.com
Will earnings trigger a reversal in Anixa Biosciences Inc.Weekly Volume Report & Risk Managed Investment Strategies - newser.com
How to use a screener to detect Anixa Biosciences Inc. breakoutsJuly 2025 Short Interest & Consistent Income Trade Recommendations - newser.com
How to manage a losing position in Anixa Biosciences Inc.Weekly Profit Recap & Free Long-Term Investment Growth Plans - newser.com
What analysts say about Anixa Biosciences Inc CY71 stockGeopolitical Risk Analysis & Minimal Risk High Reward - earlytimes.in
What drives Anixa Biosciences Inc stock priceRisk Mitigation Techniques & Build Wealth With Zero-Cost Tools - earlytimes.in
What analysts say about Anixa Biosciences Inc stockSwing Trading Ideas & Small Budget Trading Ideas - earlytimes.in
Anixa Biosciences Inc Azioni (ANIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anixa Biosciences Inc Azioni (ANIX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| KUMAR AMIT | Chief Executive Officer |
Jul 30 '25 |
Buy |
3.16 |
5,000 |
15,800 |
579,925 |
| Baskies Arnold M | Director |
Jul 18 '25 |
Buy |
3.39 |
5,000 |
16,950 |
125,000 |
| Titterton Lewis H jr | Director |
Jul 11 '25 |
Buy |
3.14 |
10,000 |
31,400 |
943,334 |
| KUMAR AMIT | Chief Executive Officer |
Jul 11 '25 |
Buy |
3.15 |
5,000 |
15,750 |
574,925 |
| KUMAR AMIT | Chief Executive Officer |
Jun 04 '25 |
Buy |
2.85 |
10,000 |
28,500 |
569,925 |
| Baskies Arnold M | Director |
Jan 28 '25 |
Buy |
2.82 |
5,000 |
14,100 |
120,000 |
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):